NRI from all over the world (excluding U.S.A. & Canada) can invest in this fund

INVEST VIA NRE/NRO

ITI Pharma and Healthcare Fund Growth for NRI [17.04]

Min Investment

5,000

Fund Size

208.21 Cr

Expense Ratio

2.4%

Exit Load

1%

SBNRI is a certified Mutual Fund distributor registered with Association of Mutual Funds in India (AMFI) with Reg. No. 246671

17.04

-0.31%

NAV as on 17 Dec 24, 12:00 AM

very high risk

sector healthcare

equity

NAV as on 17 Dec 24, 12:00 AM

very high risk

sector healthcare

equity

43.53%p.a.

Last 1Y

20.71%p.a.

Last 3Y

0.00%p.a.

Last 5Y

19.20%p.a.

Since Inception

About ITI Pharma and Healthcare Fund Growth for NRIs

NRIs can achieve long-term capital appreciation by investing in the ITI Pharma and Healthcare Fund Growth scheme from ITI Asset Management Limited. It is a Sector - Healthcare mutual fund scheme that predominantly invests in Sector - Healthcare stocks of companies. Launched on Nov 2021, ITI Pharma and Healthcare Fund Growth is Sector - Healthcare fund of its category with 208.21 Cr fund under management as on Dec 2024. The expense ratio of this fund is less than that of most other Fund category Sector - Healthcare funds.

  • ITI Pharma and Healthcare Fund Growth delivered 43.5% annual returns during the last year. It has delivered 19.2% average annual returns since the fund was launched.
  • ITI Pharma and Healthcare Fund Growth scheme tends to consistently deliver higher returns than most schemes in the same category.
  • The scheme has predominantly invested in equity

Fund Objective

The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare. However, there can be no assurance that the investment objective of the scheme would be achieved.

Top 10 Holdings

Sun Pharmaceuticals Industries Ltd

15.23%

Lupin Ltd

6.02%

Suven Pharmaceuticals Ltd

5.76%

Aurobindo Pharma Ltd

4.85%

Divi's Laboratories Ltd

4.77%

Apollo Hospitals Enterprise Ltd

4.75%

Torrent Pharmaceuticals Ltd

3.70%

Max Healthcare Institute Ltd Ordinary Shares

3.53%

Laurus Labs Ltd

3.20%

Syngene International Ltd

2.71%

Fund Managers

  1. Dhimant Shah (Dec 2022 - Present)
  2. Rohan Korde (Nov 2021 - Present)

Key Information

View Scheme Document

ITI Pharma and Healthcare Fund Growth SIP Calculator

If invested

5,000

per month

For a period of

Investment of 0 could have been

0(+0.0%)

0 (+0.0%)

This Fund

0 (+0.0%)

Fixed Deposit

NRI Mutual Fund Tax on ITI Pharma and Healthcare Fund Growth

Just like for resident investors, capital gains from mutual fund investments are subject to income tax for NRI investors.

Fund TypeShort-term Capital Gains (STCG) TaxLong-term Capital Gains (LTCG) Tax
Equity mutual funds15%10% (above Rs. 1 lakh LTCG) without indexation*
Debt & other types of fundsAt tax slab rate20% with indexation benefits

How can NRIs invest in ITI Pharma and Healthcare Fund Growth?

NRIs and OCIs can download the SBNRI app to invest in mutual funds from the country of their residence. Here are a few simple steps you need to take:

  • Complete your NRI KYC: Type in your personal details and attach supporting documents, like:
  • PAN Number
  • Overseas address proof: Any of – Water/electricity bill, postpaid mobile/internet bill, rent agreement, driving license, etc.
  • Passport – front and back
  • Passport size photograph
  • signature

If all details are correct, your KYC will be approved within 7 to 8 business days.

  • Onboarding: After KYC, you need to share the following details to complete onboarding process and start investing in ITI Pharma and Healthcare Fund Growth
  • Onboarding: After KYC, you need to share the following details to complete onboarding process and start investing:
  • City and country of birth
  • NRE/NRO bank account statement/ canceled cheque for the latest 3 months
  • Nominee details

Frequently Asked Questions